Several indications and molecules were approved in October by FDA including the following: 1- Brexucabtagene autoleucel for adult patients with...
Oncology
Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
Several indications and molecules were approved in July by FDA including the following: Asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component...
The FDA approved several medications in May including the following: Infigratinib, a kinase inhibitor for adults with previously treated, unresectable...
Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
In September, the FDA approved 2 new medications in the oncology & hematology category. Pralsetinib was approved for adult patients...
We are witnessing a new hope for patients with triple-negative breast cancer. The FDA recently approved a new antibody-drug conjugated...
In August 2020, the FDA approved the following (3) products Liquid biopsy next-generation sequencing-based FoundationOne Liquid CDx test for Foundation...
